|[June 27, 2014]
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Auxilium Pharmaceuticals Inc. and Its Board of Directors In Connection With the Sale of the Company to QLT Inc.
NEW YORK --(Business Wire)--
Levi & Korsinsky is investigating the Board of Directors of Auxilium
Pharmaceuticals Inc. ("Auxilium" or "the Company") (NasdaqGS:AUXL) for
possible breaches of fiduciary duty and other violations of state law in
connection with the sale of the Company to QLT Inc.(NasdaqGS:QLTI).
Click here to learn more about the investigation: http://zlk.9nl.com/auxilium-pharmaceuticals-auxl,
or call: 877-363-5972. There is no cost or obligation to you.
Undr the terms of the transaction, Auxilium shareholders will receive
3.1359 shares of QLT Inc. for each share of Auxilium they own. The
investigation concerns whether the Board of Auxilium breached their
fiduciary duties to stockholders by failing to adequately shop the
Company before agreeing to enter into this transaction, and whether QLT
Inc. is underpaying for Auxilium shares.
If you own Auxilium common stock and wish to obtain additional
information, please contact Joseph E. Levi, Esq. either via email at email@example.com
or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/auxilium-pharmaceuticals-auxl.
Levi & Korsinsky is a national firm with offices in New York, New
Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have
extensive expertise in prosecuting securities litigation involving
financial fraud, representing investors throughout the nation in
securities and shareholder lawsuits. For more information, please feel
free to contact any of the attorneys listed below. Attorney advertising.
Prior results do not guarantee similar outcomes.
[ Back To Technology News's Homepage ]